Results 61 to 70 of about 3,492,057 (185)

Natural History of Alternaria Sensitisation and Association With Asthma and Rhinitis From Childhood to Adulthood

open access: yesAllergy, EarlyView.
We aimed to characterise Alternaria sensitisation trajectories from childhood to adulthood; we compared SPT, whole‐extract sIgE and rAlt a 1, and assessed their longitudinal association with asthma and rhinitis in the Isle of Wight birth cohort. Alternaria sensitisation in the Isle of Wight Birth Cohort emerges mainly in late adolescence and, when ...
Mohammad Leily   +7 more
wiley   +1 more source

Calibración del modelo de grietas estructurales para pavimentos asfalticos en HDM-4 a las condiciones de Chile   [PDF]

open access: yes, 2002
The performance relationships developed by the World Bank, mainly those in the HDM-III and HDM-4 models, must be adapted by adjusting certain calibration factors in order to use them in the pavement management system of a country or region.
Salgado, Mauricio   +3 more
core  

Efficacy and safety of a house dust mites allergoid in patients with allergic rhinitis—PROACAROS study: protocol for a randomized controlled trial

open access: yesTrials
Background There is an important heterogeneity of the clinical research done to date for allergen immunotherapy (AIT). We plan to assess the safety and efficacy of a house dust mite (HDM) polymerized allergen extract mixture for allergic ...
Inmaculada Buendía-Jiménez   +5 more
doaj   +1 more source

Dendritic Cell α‐Ketoglutarate Regulates Tfh Polarization in Allergy

open access: yesAllergy, EarlyView.
Allergen induces a dendritic cell metabolism shift toward glutaminolysis with α‐ketoglutarate as a regulator of Tfh subset polarization. Glutaminolysis is required for DC allergen uptake, co‐stimulatory molecule expression, and CLR expression. Modulation of glutaminolysis, JmjD3 histone demethylation, or HIF‐1α degradation alters Tfh polarization and ...
Anuj Tharakan   +16 more
wiley   +1 more source

Deficiency of Mitochondrial Fatty Acid Enzyme, CPT1A, Underlies Airway Epithelial Barrier Dysfunction in Severe Asthma

open access: yesAllergy, EarlyView.
Mitochondrial fatty acid enzyme, CPT1A, is deficient in the airway epithelium of severe asthma patients. Restoration of CPT1A expression improved epithelial barrier integrity via increasing mitochondrial respiration and ATP production in airway epithelial cells. Restoration of deficient epithelial CPT1A may represent a new treatment approach for severe
Muyun Wang   +12 more
wiley   +1 more source

Carlos III: especial visita majestades Escuela Politécnica [PDF]

open access: yes, 1999
Revista mensual de la Universidad Carlos III de MadridNúmero especial de la revista Carlos ...
Universidad Carlos III de Madrid
core  

INNOVATIONS IN AL AMYLOIDOSIS MANAGEMENT

open access: yesHematology, Transfusion and Cell Therapy
Introduction: Immunoglobulin light chain (AL) amyloidosis is the most common type of systemic amyloidosis. AL amyloidosis is considered a plasma cell disorder caused by generally small and slowly proliferating clone of plasma cells in bone marrow that ...
Hande Oğul Sücüllü
doaj   +1 more source

m6A‐Related Regulation of Ferroptosis Contributes to Nasal Epithelial Barrier Dysfunction in Allergic Rhinitis

open access: yesAllergy, EarlyView.
This study uses human nasal epithelial cells and BALB/c mice to evaluate the role and molecular mechanism of ferroptosis in HDM‐induced AR, focusing on ferroptosis‐related responses and nasal epithelial barrier disruption. HDM exposure induces lipid peroxidation‐driven ferroptosis and epithelial barrier disruption.
Zehua Lin   +9 more
wiley   +1 more source

Carlos III: especial guerra de Kosovo [PDF]

open access: yes, 1999
Revista mensual de la Universidad Carlos III de MadridNúmero especial de la revista Carlos ...
Universidad Carlos III de Madrid
core  

Factors for Success and Failure of Allergen Immunotherapy (AIT) Trial Design in the Light of Evidence‐Based Medicine: Current Aspects 2026

open access: yesAllergy, EarlyView.
ABSTRACT Allergen immunotherapy (AIT) has been acknowledged as the only disease‐modifying treatment for respiratory diseases since its introduction in 1911. Although the efficacy and safety have convincingly been established in numerous randomized clinical trials (RCTs), the AIT study results may vary substantially.
Roy Gerth van Wijk   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy